本次公开发行情况               发行价（元/股）                                                                                                                                                                                                                                                                                                        29.88      停牌前收盘价（元/股）    35.5

                               发行市盈率                                                                                                                                                                                                                                                                                                             46.01倍    停牌前总市值（亿元）     27.3

                               定价方式                                                                                                                                                                                                                                                                                                               询价       募集资金总额（万元）     3585.6

                               是否向战略投资者配售                                                                                                                                                                                                                                                                                                   \                                       

财务表现                       营业收入（亿元）                                                                                                                                                                                                                                                                                                       3.83       3.91                     3.31

（2017年-2019年）                                                                                                                                                                                                                                                                                                                                                                             

                               归母净利润（万元）                                                                                                                                                                                                                                                                                                     9050.08    10341.54                 6345.28

                               毛利率                                                                                                                                                                                                                                                                                                                 68.28%     73.07%                   63.42%

本次募资用途                   兽用生物制品的研制与开发                                                                                                                                                                                                                                                                                                                                       

主营业务简介                   公司是一家集兽用生物制品研发、生产、销售和技术服务为一体的生物医药企业，主要产品为猪用疫苗和禽用疫苗。公司核心产品市场地位突出，2017 年和 2018 年，公司猪瘟疫苗产品全国市场份额排名均为行业第一，高致病性猪繁殖与呼吸综合征活疫苗产品全国市场份额排名均为行业第二，禽流感灭活疫苗产品全国市场份额排名均为行业第六。